Search Results

development, the field has remained too focused on ion channels like NAV1.8 , despite these targets falling

We express our gratitude to the speakers for their excellent talks. If you are interested in giving a talk, contact us at Hello@DrGPCR.com, and if you would like to present

If your pitch doesn’t immediately tell them who it’s for, why it matters, and what makes it different They’re trying to understand the opportunity. 👉 Opening with mechanisms forces the listener to do all If your listener doesn’t know what to do next or who should be involved, the conversation stalls. ✅ A If your pitch keeps stalling, stop editing your deck. Start refining your message.

physiological and pathological relevance of these interactions, since this additional level of molecular cross-talk

biology Disease physiology involves many interconnected systems Drug concentrations constantly rise and fall Time Matters More Than Potency For decades, discovery teams prioritized potency above all else. When PK Ends Programs Discovery teams often fall in love with molecules that show beautiful activity

Sandra Berndt talk about new structural perspectives in GPCR-mediated Src family kinase activation.

Joe Clayton from BioTek Instruments talk about automated micro-plate-based methods for quantifying #GPCR

Join us now, and let's explore with all our might! We aim to make education accessible to all! 🎉 We are bouncing off the walls with excitement to meet you all and geek out about GPCRs. Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Neurocrine Biosciences Announces Conference Call Webcast of Third Quarter 2024 Financial Results Novel full MC4 receptor-specific nanobody described Call

Come attend this month's virtual café talk to see the awesome work of Dr.

Hello GPCR Minds,   This week, you'll learn all about Terry’s Pharmacology Corner, your new learning GPCR mutations in cancer   show both driver-like patterns and high redundancy, prompting a call for multiomics

GPR110 belongs to adhesion GPCR and was the functional receptor of N-docosahexaenoyl ethanolamine (also called

You can find more details about the speakers on the Live Talks page, and make sure to mark your calendar November 20 - 23, 2023 | ASCEPT Annual Scientific Meeting NEW January 16 - 19, 2024 | 23rd Annual PEP Talk

Join us for another virtual cafe talk to hear about the amazing work that Dr.

Thus, we call them gluopsins.

traverse a dynamically revealed hydrophilic groove between transmembrane helices (TM) 6 and 7 while their tails

You can find all the necessary information on the Logo Contest page. Did you know that as a premium member, you enjoy exclusive access to recorded talks from our Dr. Also, If you attended any of the talks, we'd truly value your feedback through our survey.

APEX2 biosensor utilizes a fluorogenic substrate called Amplex UltraRed (AUR).

We demonstrate how tail composition plays a role in modulating the binding of PI(4,5)P2 lipids to GCGR

We extend immense gratitude to our exceptional speakers and all attendees who participated. Completes Recruitment of Patients Sanyou Bio's Evolution of Bioprocess Enhancement for CHO Cell Lines: A Talk Conference November 20 - 23, 2023 | ASCEPT Annual Scientific Meeting January 16 - 19, 2024 | 23rd Annual PEP Talk

One successful strategy is the so-called metabolic surgery whose beneficial effects are beyond dietary

Investor calls take too long before reaching substance. conversation drifts in a different direction , depending on who is asking the questions 2️⃣ Investor calls In reality, they all point to the same underlying problem .

Join us for the first virtual cafe talk to hear about the amazing work that Dr.

Teams that rely only on skill depth struggle here because skills alone do not tell people how to act They determine whether skills can be applied at all.   the problem, adjust priorities, and make decisions that preserve momentum without pretending to have all Survival traits reveal themselves in how people talk about uncertainty, ownership, and unfinished work biotech environments. 1️⃣ How candidates describe moments without clear answers: Listen to how they talk

“GPCRs present unique challenges for antibody development,” said Alexander Ball, Jr., M.D., Senior Scientist

Sotrovimab is the first monoclonal antibody showing preclinical efficacy against all COVID-19 variants , including the delta and omicron mutations, Vir CEO George Scangos said on a Dec. 7 call with analysts

its high chemoresistance and the presence of a cell subpopulation that persists under hypoxic niches, called

ACKR1) was discovered on erythrocytes as the Duffy blood group antigen ( Cutbush et al., 1950 ), also called

company also presented data highlighting patient preferences and treatment patterns in classic CAH in Hall

Everyone’s rushing from one talk to the next. But the truth? trailblazing CRO making cryo-electron microscopy (cryo-EM) accessible to pharma and biotech companies of all

GPCR community live on April 16 — one of 12+ Masterclasses planned for 2026, all included in Premium. Learn More ➤ This live session with recording available as well as all masterclasses are now included The questions that don't make it into talks.